{"id":15896,"date":"2018-11-09T14:07:49","date_gmt":"2018-11-09T14:07:49","guid":{"rendered":"https:\/\/celonpharma.com\/?p=15896"},"modified":"2018-11-09T14:07:49","modified_gmt":"2018-11-09T14:07:49","slug":"celon-pharma-o-rozwoju-lekow-onkologicznych-na-eortc-nci-aacr-symposium","status":"publish","type":"post","link":"https:\/\/celon.group\/en\/2018\/11\/09\/celon-pharma-o-rozwoju-lekow-onkologicznych-na-eortc-nci-aacr-symposium\/","title":{"rendered":"Celon Pharma on the development of cancer drugs at the ORTC-NCI-AACR SYMPOSIUM"},"content":{"rendered":"

Aleksandra Sta\u0144czak, PhD, Leader of the Oncology Research Group will present results for two inhibitors under Celon Pharma\u2019s development at the 30th symposium organised by European Organisation for Research and Treatment of Cancer (EORTC), National Cancer Institute (NCI) and\u00a0 American Association for Cancer Research (AACR), to be held on 13-16. November in Dublin.<\/p>\n

The following projects will be presented in the poster session:<\/p>\n

    \n
  1. CPL-410-005, a novel ubiquitin-activating enzyme (UAE) inhibitor in preclinical evaluation as an anticancer treatment for solid tumors.<\/li>\n
  2. Rational-based drug design of novel, highly potent MER inhibitors as potential treatment of cancers.<\/li>\n<\/ol>\n

    The latest reports on the development of cancer drugs will be presented at the Symposium. The meeting will be participated by scientists and representatives of the pharmaceutical sector from around the world.<\/p>\n","protected":false},"excerpt":{"rendered":"

    Aleksandra Sta\u0144czak, PhD, Leader of the Oncology Research Group will present results for two inhibitors under Celon Pharma\u2019s development at the 30th symposium organised by European Organisation for Research and Treatment of Cancer (EORTC), National Cancer Institute (NCI) and\u00a0 American Association for Cancer Research (AACR), to be held on 13-16. November in Dublin. The followingRead more »<\/a><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[26],"tags":[],"class_list":["post-15896","post","type-post","status-publish","format-standard","hentry","category-general-en"],"acf":[],"yoast_head":"\nCelon Pharma on the development of cancer drugs at the ORTC-NCI-AACR SYMPOSIUM - CelonGROUP<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/celon.group\/en\/2018\/11\/09\/celon-pharma-o-rozwoju-lekow-onkologicznych-na-eortc-nci-aacr-symposium\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Celon Pharma on the development of cancer drugs at the ORTC-NCI-AACR SYMPOSIUM - CelonGROUP\" \/>\n<meta property=\"og:description\" content=\"Aleksandra Sta\u0144czak, PhD, Leader of the Oncology Research Group will present results for two inhibitors under Celon Pharma\u2019s development at the 30th symposium organised by European Organisation for Research and Treatment of Cancer (EORTC), National Cancer Institute (NCI) and\u00a0 American Association for Cancer Research (AACR), to be held on 13-16. November in Dublin. The followingRead more »\" \/>\n<meta property=\"og:url\" content=\"http:\/\/celon.group\/en\/2018\/11\/09\/celon-pharma-o-rozwoju-lekow-onkologicznych-na-eortc-nci-aacr-symposium\/\" \/>\n<meta property=\"og:site_name\" content=\"CelonGROUP\" \/>\n<meta property=\"article:published_time\" content=\"2018-11-09T14:07:49+00:00\" \/>\n<meta name=\"author\" content=\"Ma\u0142gorzata Siewierska\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ma\u0142gorzata Siewierska\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/celon.group\/en\/2018\/11\/09\/celon-pharma-o-rozwoju-lekow-onkologicznych-na-eortc-nci-aacr-symposium\/\",\"url\":\"http:\/\/celon.group\/en\/2018\/11\/09\/celon-pharma-o-rozwoju-lekow-onkologicznych-na-eortc-nci-aacr-symposium\/\",\"name\":\"Celon Pharma on the development of cancer drugs at the ORTC-NCI-AACR SYMPOSIUM - CelonGROUP\",\"isPartOf\":{\"@id\":\"https:\/\/celon.group\/en\/#website\"},\"datePublished\":\"2018-11-09T14:07:49+00:00\",\"author\":{\"@id\":\"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf\"},\"breadcrumb\":{\"@id\":\"http:\/\/celon.group\/en\/2018\/11\/09\/celon-pharma-o-rozwoju-lekow-onkologicznych-na-eortc-nci-aacr-symposium\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/celon.group\/en\/2018\/11\/09\/celon-pharma-o-rozwoju-lekow-onkologicznych-na-eortc-nci-aacr-symposium\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/celon.group\/en\/2018\/11\/09\/celon-pharma-o-rozwoju-lekow-onkologicznych-na-eortc-nci-aacr-symposium\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/celon.group\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Celon Pharma on the development of cancer drugs at the ORTC-NCI-AACR SYMPOSIUM\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/celon.group\/en\/#website\",\"url\":\"https:\/\/celon.group\/en\/\",\"name\":\"CelonGROUP\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/celon.group\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf\",\"name\":\"Ma\u0142gorzata Siewierska\",\"url\":\"https:\/\/celon.group\/en\/author\/malgorzata-siewierska\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Celon Pharma on the development of cancer drugs at the ORTC-NCI-AACR SYMPOSIUM - CelonGROUP","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/celon.group\/en\/2018\/11\/09\/celon-pharma-o-rozwoju-lekow-onkologicznych-na-eortc-nci-aacr-symposium\/","og_locale":"en_US","og_type":"article","og_title":"Celon Pharma on the development of cancer drugs at the ORTC-NCI-AACR SYMPOSIUM - CelonGROUP","og_description":"Aleksandra Sta\u0144czak, PhD, Leader of the Oncology Research Group will present results for two inhibitors under Celon Pharma\u2019s development at the 30th symposium organised by European Organisation for Research and Treatment of Cancer (EORTC), National Cancer Institute (NCI) and\u00a0 American Association for Cancer Research (AACR), to be held on 13-16. November in Dublin. The followingRead more »","og_url":"http:\/\/celon.group\/en\/2018\/11\/09\/celon-pharma-o-rozwoju-lekow-onkologicznych-na-eortc-nci-aacr-symposium\/","og_site_name":"CelonGROUP","article_published_time":"2018-11-09T14:07:49+00:00","author":"Ma\u0142gorzata Siewierska","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ma\u0142gorzata Siewierska","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/celon.group\/en\/2018\/11\/09\/celon-pharma-o-rozwoju-lekow-onkologicznych-na-eortc-nci-aacr-symposium\/","url":"http:\/\/celon.group\/en\/2018\/11\/09\/celon-pharma-o-rozwoju-lekow-onkologicznych-na-eortc-nci-aacr-symposium\/","name":"Celon Pharma on the development of cancer drugs at the ORTC-NCI-AACR SYMPOSIUM - CelonGROUP","isPartOf":{"@id":"https:\/\/celon.group\/en\/#website"},"datePublished":"2018-11-09T14:07:49+00:00","author":{"@id":"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf"},"breadcrumb":{"@id":"http:\/\/celon.group\/en\/2018\/11\/09\/celon-pharma-o-rozwoju-lekow-onkologicznych-na-eortc-nci-aacr-symposium\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/celon.group\/en\/2018\/11\/09\/celon-pharma-o-rozwoju-lekow-onkologicznych-na-eortc-nci-aacr-symposium\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/celon.group\/en\/2018\/11\/09\/celon-pharma-o-rozwoju-lekow-onkologicznych-na-eortc-nci-aacr-symposium\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celon.group\/en\/"},{"@type":"ListItem","position":2,"name":"Celon Pharma on the development of cancer drugs at the ORTC-NCI-AACR SYMPOSIUM"}]},{"@type":"WebSite","@id":"https:\/\/celon.group\/en\/#website","url":"https:\/\/celon.group\/en\/","name":"CelonGROUP","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celon.group\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf","name":"Ma\u0142gorzata Siewierska","url":"https:\/\/celon.group\/en\/author\/malgorzata-siewierska\/"}]}},"_links":{"self":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts\/15896","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/comments?post=15896"}],"version-history":[{"count":0,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts\/15896\/revisions"}],"wp:attachment":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/media?parent=15896"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/categories?post=15896"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/tags?post=15896"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}